We propose a new application of molecular shape descriptors in hierarchical selection during virtual screening (VS). Here, a structure-based pharmacophore and docking-guided VS protocol have been evolved to identify inhibitors against adenosine kinase (AK). The knowledge gained on the shape requirements has been extrapolated in classifying active and inactive molecules against this target. This classification enabled us to pick the appropriate ligand conformation in the binding site. We have suggested a set of hierarchical filters for VS, from a simple molecular shape analysis (MSA) descriptor-based recursive models to docking scores. This approach permits a systematic study to understand the importance of spatial requirements and limitatio...
Abstract: Structure-based drug discovery (SBDD) is becoming an essential tool in assisting fast and ...
<p>Discovery of new pharmaceutical substances is currently boosted by the possibility of utilization...
Computational docking as a means to prioritise small molecules in drug discovery projects remains a ...
Computational methods involving virtual screening could potentially be employed to discover new biom...
Computational methods involving virtual screening could potentially be employed to discover new biom...
Computational methods involving virtual screening could potentially be employed to discover new biom...
Discovery of new pharmaceutical substances is currently boosted by the possibility of utilization of...
This PhD thesis was focused on the exploration and study of different computational strategies that ...
<p>Discovery of new pharmaceutical substances is currently boosted by the possibility of utilization...
<p>Discovery of new pharmaceutical substances is currently boosted by the possibility of utilization...
Tropomyosin-related kinase A (TrkA) is a promising target for the development of cancer and pain the...
<p>Discovery of new pharmaceutical substances is currently boosted by the possibility of utilization...
<p>Discovery of new pharmaceutical substances is currently boosted by the possibility of utilization...
<p>Discovery of new pharmaceutical substances is currently boosted by the possibility of utilization...
Virtual screening methods are now widely used in early stages of drug discovery, aiming to rank pote...
Abstract: Structure-based drug discovery (SBDD) is becoming an essential tool in assisting fast and ...
<p>Discovery of new pharmaceutical substances is currently boosted by the possibility of utilization...
Computational docking as a means to prioritise small molecules in drug discovery projects remains a ...
Computational methods involving virtual screening could potentially be employed to discover new biom...
Computational methods involving virtual screening could potentially be employed to discover new biom...
Computational methods involving virtual screening could potentially be employed to discover new biom...
Discovery of new pharmaceutical substances is currently boosted by the possibility of utilization of...
This PhD thesis was focused on the exploration and study of different computational strategies that ...
<p>Discovery of new pharmaceutical substances is currently boosted by the possibility of utilization...
<p>Discovery of new pharmaceutical substances is currently boosted by the possibility of utilization...
Tropomyosin-related kinase A (TrkA) is a promising target for the development of cancer and pain the...
<p>Discovery of new pharmaceutical substances is currently boosted by the possibility of utilization...
<p>Discovery of new pharmaceutical substances is currently boosted by the possibility of utilization...
<p>Discovery of new pharmaceutical substances is currently boosted by the possibility of utilization...
Virtual screening methods are now widely used in early stages of drug discovery, aiming to rank pote...
Abstract: Structure-based drug discovery (SBDD) is becoming an essential tool in assisting fast and ...
<p>Discovery of new pharmaceutical substances is currently boosted by the possibility of utilization...
Computational docking as a means to prioritise small molecules in drug discovery projects remains a ...